Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Viewpoint

Vol. 148 No. 0506 (2018)

Craniopharyngioma – a chronic disease

  • Hermann L. Müller
DOI
https://doi.org/10.4414/smw.2018.14548
Cite this as:
Swiss Med Wkly. 2018;148:w14548
Published
07.02.2018

References

  1. Müller HL. Craniopharyngioma. Endocr Rev. 2014;35(3):513–43. doi:.https://doi.org/10.1210/er.2013-1115
  2. Müller HL, Merchant TE, Puget S, Martinez-Barbera JP. New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma. Nat Rev Endocrinol. 2017;13(5):299–312. doi:.https://doi.org/10.1038/nrendo.2016.217
  3. Sterkenburg AS, Hoffmann A, Gebhardt U, Warmuth-Metz M, Daubenbüchel AM, Müller HL. Survival, hypothalamic obesity, and neuropsychological/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neuro-oncol. 2015;17(7):1029–38. doi:.https://doi.org/10.1093/neuonc/nov044
  4. Bishop AJ, Greenfield B, Mahajan A, Paulino AC, Okcu MF, Allen PK, et al. Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys. 2014;90(2):354–61. doi:.https://doi.org/10.1016/j.ijrobp.2014.05.051
  5. Elowe-Gruau E, Beltrand J, Brauner R, Pinto G, Samara-Boustani D, Thalassinos C, et al. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab. 2013;98(6):2376–82. doi:.https://doi.org/10.1210/jc.2012-3928
  6. Kilday JP, Caldarelli M, Massimi L, Chen RH, Lee YY, Liang ML, et al. Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN. Neuro-oncol. 2017;19(10):1398–407. doi:.https://doi.org/10.1093/neuonc/nox056
  7. Müller HL. Consequences of craniopharyngioma surgery in children. J Clin Endocrinol Metab. 2011;96(7):1981–91. doi:.https://doi.org/10.1210/jc.2011-0174
  8. Müller HL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes. 2016;23(1):81–9. doi:.https://doi.org/10.1097/MED.0000000000000214
  9. Müller HL. Risk-adapted treatment and follow-up management in childhood-onset craniopharyngioma. Expert Rev Neurother. 2016;16(5):535–48. doi:.https://doi.org/10.1586/14737175.2016.1166959
  10. Andereggen L, Hess B, Andres RH, El-Koussy M, Mariani L, Raabe A, et al. A ten-year follow-up study of the treatment outcome of craniopharyngiomas. Swiss Med Wkly. 2018;148:w14521. https://doi.org/10.4414/smw.2018.14521/
  11. Bretault M, Boillot A, Muzard L, Poitou C, Oppert JM, Barsamian C, et al. Clinical review: Bariatric surgery following treatment for craniopharyngioma: a systematic review and individual-level data meta-analysis. J Clin Endocrinol Metab. 2013;98(6):2239–46. doi:.https://doi.org/10.1210/jc.2012-4184
  12. Müller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, et al. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab. 2004;89(7):3298–305. doi:.https://doi.org/10.1210/jc.2003-031751
  13. Müller HL. Craniopharyngioma: long-term consequences of a chronic disease. Expert Rev Neurother. 2015;15(11):1241–4. doi:.https://doi.org/10.1586/14737175.2015.1100078
  14. Hankinson TC, Palmeri NO, Williams SA, Torok MR, Serrano CA, Foreman NK, et al. Patterns of care for craniopharyngioma: survey of members of the american association of neurological surgeons. Pediatr Neurosurg. 2013;49(3):131–6. doi:.https://doi.org/10.1159/000357783
  15. Hoffmann A, Warmth-Metz M, Gebhardt U, Pietsch T, Pohl F, Kortmann RD, et al. Childhood craniopharyngioma - changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000/2007. Klin Padiatr. 2014;226(3):161–8. doi:.https://doi.org/10.1055/s-0034-1368785
  16. Müller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, Pohl F, et al.; Kraniopharyngeom 2000 Study Committee. Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. J Clin Endocrinol Metab. 2012;97(11):3935–43. doi:.https://doi.org/10.1210/jc.2012-2069
  17. Müller HL, Gebhardt U, Teske C, Faldum A, Zwiener I, Warmuth-Metz M, et al.; Study Committee of KRANIOPHARYNGEOM 2000. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up. Eur J Endocrinol. 2011;165(1):17–24. doi:.https://doi.org/10.1530/EJE-11-0158
  18. Puget S, Garnett M, Wray A, Grill J, Habrand JL, Bodaert N, et al. Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurg. 2007;106(1, Suppl):3–12. doi:.https://doi.org/10.3171/ped.2007.106.1.3